Neuroscience Antibodies & Assays Market Report 2026
Download Free Sample Buy Now
Neuroscience Antibodies & Assays Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Neuroscience Antibodies & Assays Market Report 2026

Global Outlook – By Product (Consumables, Instruments), By Technology (Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies), By Application (In Vitro Diagnostics, Research, Drug Discovery), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neuroscience Antibodies & Assays Market Overview

• Neuroscience Antibodies & Assays market size has reached to $5.03 billion in 2025

• Expected to grow to $9.83 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%

• Growth Driver: Surge In Neurological Illnesses Spurs Remarkable Growth In The Neuroscience Antibodies & Assays Market

• Market Trend: Next-Generation Immunoassays Enable Non-Invasive Brain Health Monitoring

• North America was the largest region in 2025.

What Is Covered Under Neuroscience Antibodies & Assays Market?

The neuroscience antibodies & assays are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system. Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system. Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

The main types of neuroscience antibodies & assays market products are consumables, and instruments. Consumables are used in many neurological studies and research experiments. Consumable includes assay kits, reagents, and antibodies that enable quantitative and real-time live-cell analysis. The technologies used are molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, and other technologies. The various applications are in vitro diagnostics, research, and drug discovery. The various end users are hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies.

Neuroscience Antibodies & Assays market report bar graph

What Is The Neuroscience Antibodies & Assays Market Size and Share 2026?

The neuroscience antibodies & assays market size has grown rapidly in recent years. It will grow from $5.03 billion in 2025 to $5.76 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of neuroscience research funding, increased use of immunoassays in diagnostics, availability of advanced laboratory instruments, growth of academic neuroscience programs.

What Is The Neuroscience Antibodies & Assays Market Growth Forecast?

The neuroscience antibodies & assays market size is expected to see rapid growth in the next few years. It will grow to $9.83 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to increasing investments in neurodegenerative disease research, rising demand for personalized neurology diagnostics, expansion of drug discovery programs, growing adoption of automated assay platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of high-specificity antibody reagents, rising use of multiplex assay platforms, growing integration of automation in neuro research labs, expansion of biomarker-based neurological studies, enhanced focus on reproducibility and sensitivity.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neuroscience Antibodies & Assays Market Segmentation

1) By Product: Consumables, Instruments

2) By Technology: Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies

3) By Application: In Vitro Diagnostics, Research, Drug Discovery

4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

Subsegments:

1) By Consumables: Antibodies, Assay Kits

2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations

What Is The Driver Of The Neuroscience Antibodies & Assays Market?

The increase in incidents of neurological illnesses is expected to propel the growth of the neuroscience antibodies and assays market going forward. Neurological illnesses are disorders affecting the brain, spinal cord, and nerves that result in impaired cognitive, motor, or sensory functions. The rising incidents of neurological illnesses are largely driven by population aging, as the growing proportion of older adults in developed countries increases the prevalence of age-related neurological conditions such as Alzheimer's disease and Parkinson's disease. Increasing neurological illness incidents support demand for specialized antibodies and assays because researchers and clinicians require these diagnostic and research tools to detect, study, and monitor disease-specific biomarkers and protein abnormalities in neurological conditions. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to rise to 13.8 million by 2060. Therefore, the increase in incidents of neurological illnesses is driving the growth of the neuroscience antibodies and assays market.

Key Players In The Global Neuroscience Antibodies & Assays Market

Major companies operating in the neuroscience antibodies & assays market are Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

Global Neuroscience Antibodies & Assays Market Trends and Insights

Major companies operating in the neuroscience antibodies and assays market are focusing on developing innovative products, such as bispecific in vivo–ready antibodies, to simultaneously target multiple neurological pathways for more precise and effective research outcomes. Bispecific in vivo–ready antibodies are engineered to bind two different targets simultaneously and are formulated for use in live animal models, helping researchers modulate multiple neurological pathways at once for more precise and physiologically relevant neuroscience studies. For instance, in October 2025, Bio X Cell LLC, a US–based biotechnology company, launched an expanded catalog of bispecific and ADC (antibody-drug conjugate) antibodies as part of its refreshed brand identity, targeting advanced preclinical neuroscience and translational research applications. These bispecific antibodies are engineered to bind two distinct antigens simultaneously, allowing researchers to modulate multiple signaling pathways or cell populations in the brain within a single study, unlike traditional monoclonal antibodies that target only one molecule. They are produced with high purity (= 95%) and ultra-low endotoxin levels (= 0.5 EU/mg), making them suitable for sensitive in vivo experiments, organoid models, and organ-on-chip systems. The ADCs combine a functional antibody with a cytotoxic payload to selectively target specific neuronal or glial populations, offering precise modulation and experimental flexibility.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Neuroscience Antibodies & Assays Market?

In December 2023, Danaher Corporation, a US-based life sciences & diagnostics company, acquired Abcam plc for an undisclosed amount. With this acquisition, Danaher aimed to expand its life science reagents and consumables platform, enhance its protein tool capabilities for research and diagnostics, accelerate growth in the life sciences ecosystem, and bolster its global reach in supplying integrated solutions to researchers and clinicians. Abcam plc is a UK-based biotechnology company that specializes in providing antibodies, reagents, assays and related life science research tools.

Regional Outlook

North America was the largest region in the neuroscience antibodies & assays market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Neuroscience Antibodies & Assays Market?

The neuroscience antibodies & assays market consists of sales of antibodies and assay kits and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuroscience Antibodies & Assays Market Report 2026?

The neuroscience antibodies & assays market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience antibodies & assays industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neuroscience Antibodies & Assays Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $5.76 billion
Revenue Forecast In 2035 $9.83 billion
Growth Rate CAGR of 14.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Technology, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neuroscience Antibodies & Assays Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neuroscience Antibodies & Assays Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neuroscience Antibodies & Assays Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neuroscience Antibodies & Assays Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of High-Specificity Antibody Reagents

4.2.2 Rising Use Of Multiplex Assay Platforms

4.2.3 Growing Integration Of Automation In Neuro Research Labs

4.2.4 Expansion Of Biomarker-Based Neurological Studies

4.2.5 Enhanced Focus On Reproducibility And Sensitivity

5. Neuroscience Antibodies & Assays Market Analysis Of End Use Industries

5.1 Hospitals And Diagnostics Centers

5.2 Academic And Research Institutes

5.3 Pharmaceutical Companies

5.4 Biotechnology Companies

5.5 Contract Research Organizations

6. Neuroscience Antibodies & Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuroscience Antibodies & Assays Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neuroscience Antibodies & Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neuroscience Antibodies & Assays Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neuroscience Antibodies & Assays Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neuroscience Antibodies & Assays Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuroscience Antibodies & Assays Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuroscience Antibodies & Assays Market Segmentation

9.1. Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consumables, Instruments

9.2. Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies

9.3. Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

In Vitro Diagnostics, Research, Drug Discovery

9.4. Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

9.5. Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antibodies, Assay Kits

9.6. Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations

10. Neuroscience Antibodies & Assays Market Regional And Country Analysis

10.1. Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuroscience Antibodies & Assays Market

11.1. Asia-Pacific Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuroscience Antibodies & Assays Market

12.1. China Neuroscience Antibodies & Assays Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuroscience Antibodies & Assays Market

13.1. India Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuroscience Antibodies & Assays Market

14.1. Japan Neuroscience Antibodies & Assays Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuroscience Antibodies & Assays Market

15.1. Australia Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuroscience Antibodies & Assays Market

16.1. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuroscience Antibodies & Assays Market

17.1. South Korea Neuroscience Antibodies & Assays Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuroscience Antibodies & Assays Market

18.1. Taiwan Neuroscience Antibodies & Assays Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuroscience Antibodies & Assays Market

19.1. South East Asia Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuroscience Antibodies & Assays Market

20.1. Western Europe Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuroscience Antibodies & Assays Market

21.1. UK Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuroscience Antibodies & Assays Market

22.1. Germany Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuroscience Antibodies & Assays Market

23.1. France Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuroscience Antibodies & Assays Market

24.1. Italy Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuroscience Antibodies & Assays Market

25.1. Spain Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuroscience Antibodies & Assays Market

26.1. Eastern Europe Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuroscience Antibodies & Assays Market

27.1. Russia Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuroscience Antibodies & Assays Market

28.1. North America Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuroscience Antibodies & Assays Market

29.1. USA Neuroscience Antibodies & Assays Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuroscience Antibodies & Assays Market

30.1. Canada Neuroscience Antibodies & Assays Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuroscience Antibodies & Assays Market

31.1. South America Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuroscience Antibodies & Assays Market

32.1. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuroscience Antibodies & Assays Market

33.1. Middle East Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuroscience Antibodies & Assays Market

34.1. Africa Neuroscience Antibodies & Assays Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Neuroscience Antibodies & Assays Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuroscience Antibodies & Assays Market Regulatory and Investment Landscape

36. Neuroscience Antibodies & Assays Market Competitive Landscape And Company Profiles

36.1. Neuroscience Antibodies & Assays Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neuroscience Antibodies & Assays Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neuroscience Antibodies & Assays Market Company Profiles

36.3.1. Abcam plc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. BioLegend Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Cell Signaling Technology Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

37. Neuroscience Antibodies & Assays Market Other Major And Innovative Companies

Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc.

38. Global Neuroscience Antibodies & Assays Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuroscience Antibodies & Assays Market

40. Neuroscience Antibodies & Assays Market High Potential Countries, Segments and Strategies

40.1 Neuroscience Antibodies & Assays Market In 2030 - Countries Offering Most New Opportunities

40.2 Neuroscience Antibodies & Assays Market In 2030 - Segments Offering Most New Opportunities

40.3 Neuroscience Antibodies & Assays Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neuroscience Antibodies & Assays Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neuroscience Antibodies & Assays Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neuroscience Antibodies & Assays Market, Supply Chain Analysis
  • Table 4: Global Neuroscience Antibodies & Assays Market, Major Raw Material Providers
  • Table 5: Global Neuroscience Antibodies & Assays Market, Major Resource Providers
  • Table 6: Global Neuroscience Antibodies & Assays Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neuroscience Antibodies & Assays Market, Major Distributors And Channel Partners
  • Table 8: Global Neuroscience Antibodies & Assays Market, Key Technologies & Future Trends
  • Table 9: Global Neuroscience Antibodies & Assays Market, Major Trends
  • Table 10: Global Neuroscience Antibodies & Assays Market, Major End Users
  • Table 11: Global Neuroscience Antibodies & Assays Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neuroscience Antibodies & Assays Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neuroscience Antibodies & Assays Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neuroscience Antibodies & Assays Market - TAM, US$ Billion, 2025
  • Table 15: Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Neuroscience Antibodies & Assays Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Neuroscience Antibodies & Assays Market - Company Scoring Matrix
  • Table 97: Abcam plc Financial Performance
  • Table 98: BioLegend Inc. Financial Performance
  • Table 99: Bio-Rad Laboratories Inc. Financial Performance
  • Table 100: Cell Signaling Technology Inc. Financial Performance
  • Table 101: F. Hoffmann-La Roche AG Financial Performance
  • Table 102: Global Neuroscience Antibodies & Assays Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Neuroscience Antibodies & Assays Market, Competitive Dashboard
  • Table 104: Global Neuroscience Antibodies & Assays Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Neuroscience Antibodies & Assays Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 106: Global, Neuroscience Antibodies & Assays Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 107: Global, Neuroscience Antibodies & Assays Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Neuroscience Antibodies & Assays Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neuroscience Antibodies & Assays Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neuroscience Antibodies & Assays Market, Supply Chain Analysis
  • Figure 4: Global Neuroscience Antibodies & Assays Market, Major Raw Material Providers
  • Figure 5: Global Neuroscience Antibodies & Assays Market, Major Resource Providers
  • Figure 6: Global Neuroscience Antibodies & Assays Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neuroscience Antibodies & Assays Market, Major Distributors And Channel Partners
  • Figure 8: Global Neuroscience Antibodies & Assays Market, Key Technologies & Future Trends
  • Figure 9: Global Neuroscience Antibodies & Assays Market, Major Trends
  • Figure 10: Global Neuroscience Antibodies & Assays Market, Major End Users
  • Figure 11: Global Neuroscience Antibodies & Assays Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neuroscience Antibodies & Assays Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neuroscience Antibodies & Assays Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neuroscience Antibodies & Assays Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neuroscience Antibodies & Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Neuroscience Antibodies & Assays Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Neuroscience Antibodies & Assays Market - Company Scoring Matrix
  • Figure 97: Abcam plc Financial Performance
  • Figure 98: BioLegend Inc. Financial Performance
  • Figure 99: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 100: Cell Signaling Technology Inc. Financial Performance
  • Figure 101: F. Hoffmann-La Roche AG Financial Performance
  • Figure 102: Global Neuroscience Antibodies & Assays Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Neuroscience Antibodies & Assays Market, Competitive Dashboard
  • Figure 104: Global Neuroscience Antibodies & Assays Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Neuroscience Antibodies & Assays Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 106: Global, Neuroscience Antibodies & Assays Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 107: Global, Neuroscience Antibodies & Assays Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Read More About Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Read More About The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Read More About Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Read More About Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Read More About Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

Animal Based Protein Supplements Market Report 2026 - Global Outlook – By Product (Protein Powder, Protein Bars, Ready-To-Drink, Other Products), By Raw Materials (Whey, Casein, Egg, Fish, Other Raw Materials), By Applic...

Magnesium Oxide Nanopowder Market Report 2026 - Global Outlook – By Type (99% Magnesium Oxide Nanopowder, 99.9% Magnesium Oxide Nanopowder, 99.99% Magnesium Oxide Nanopowder, 99.999% Magnesium Oxide Nanopowder), By Appli...

Metaverse In Education Market Report 2026 - Global Outlook – By Component (Hardware, Software, Professional Services), By Deployment (Cloud, On-Premise), By Application (Learning, Skill Development, Educational Apps, Sel...

Neuromorphic Chips Market Report 2026 - Global Outlook – By Components ( Software, Hardware), By Function ( Signal Processing, Data Processing, Image Recognition, Process optimization), By End Use Industry ( Aerospace An...

Vehicle Scanner Market Report 2026 - Global Outlook – By Scanner Type (Portable Scanner, Fixed Scanner), By Diagnostic Capability (Code Readers (Basic Diagnostics), Advanced Diagnostic Scanners), By Vehicle Type (Passeng...

Monoclonal Antibodies (MAs) Market Report 2026 - Global Outlook – By Source (Murine, Chimeric, Humanized, Human ), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacologi...

Smart Badge Market Report 2026 - Global Outlook – By Offering ( Hardware, Software ), By Type ( Smart Badges Without Display, Smart Badges With Display ), By Communication ( Contact, Contactless, NFC Technology, RFID Tec...

Frequently Asked Questions

The Neuroscience Antibodies & Assays market was valued at $5.03 billion in 2025, increased to $5.76 billion in 2026, and is projected to reach $9.83 billion by 2030.

The global Neuroscience Antibodies & Assays market is expected to grow at a CAGR of 14.3% from 2026 to 2035 to reach $9.83 billion by 2035.

Some Key Players in the Neuroscience Antibodies & Assays market Include, Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc.

Major trend in this market includes: Next-Generation Immunoassays Enable Non-Invasive Brain Health Monitoring. For further insights on this market. request a sample here

North America was the largest region in the neuroscience antibodies & assays market in 2025. The regions covered in the neuroscience antibodies & assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America,

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us